Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Intellia Therapeutics, Inc. (NTLA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/10/2023 |
SC 13G/A
| ARK Investment Management LLC reports a 11.2% stake in Intellia Therapeutics, Inc. |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 9.3% stake in Intellia Therapeutics Inc. |
| 02/09/2023 |
SC 13G/A
| FMR LLC reports a 2.9% stake in INTELLIA THERAPEUTICS INC |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2022 |
SC 13G/A
| VANGUARD GROUP INC reports a 8.7% stake in Intellia Therapeutics Inc. |
| 02/09/2022 |
SC 13G/A
| ARK Investment Management LLC reports a 10.6% stake in Intellia Therapeutics, Inc. |
| 02/04/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/03/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/26/2021 |
SC 13G/A
| ARK Investment Management LLC reports a 10.4% stake in Intellia Therapeutics, Inc. |
| 02/16/2021 |
SC 13G/A
| ARK Investment Management LLC reports a 17.4% stake in Intellia Therapeutics, Inc. |
| 02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/05/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/29/2021 |
SC 13G/A
| BlackRock Inc. reports a 8.6% stake in Intellia Therapeutics, Inc. |
| 12/09/2020 |
SC 13G/A
| Sumitomo Mitsui Trust Holdings, Inc. reports a 9.2% stake in Intellia Therapeutics, Inc. |
| 12/08/2020 |
SC 13G/A
| Nikko Asset Management Americas, Inc. reports a 9.2% stake in Intellia Therapeutics, Inc. |
| 02/14/2020 |
SC 13G/A
| ARK Investment Management LLC reports a 17.9% stake in Intellia Therapeutics, Inc. |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/05/2020 |
SC 13G/A
| BlackRock Inc. reports a 7.5% stake in Intellia Therapeutics, Inc. |
| 09/10/2019 |
SC 13G/A
| FMR LLC reports a 0.3% stake in INTELLIA THERAPEUTICS INC |
| 08/08/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/06/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 03/25/2019 |
SC 13G/A
| Caribou Biosciences, Inc. reports a 4% stake in Intellia Therapeutics, Inc. |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/08/2019 |
SC 13G/A
| Atlas Venture Fund IX, L.P. reports a 3.7% stake in INTELLIA THERAPUTICS, INC. |
| 01/16/2019 |
SC 13G/A
| Caribou Biosciences, Inc. reports a 5.8% stake in Intellia Therapeutics, Inc. |
| 02/13/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2018 |
SC 13G/A
| Atlas Venture Fund IX, L.P. reports a 8.4% stake in INTELLIA THERAPUTICS, INC. |
| 02/06/2018 |
SC 13G/A
| Caribou Biosciences, Inc. reports a 10.7% stake in Intellia Therapeutics, Inc. |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|
|